Jonathan Lipscomb

1.3k total citations
19 papers, 1.1k citations indexed

About

Jonathan Lipscomb is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jonathan Lipscomb has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Jonathan Lipscomb's work include HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (15 papers) and HIV/AIDS drug development and treatment (10 papers). Jonathan Lipscomb is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (15 papers) and HIV/AIDS drug development and treatment (10 papers). Jonathan Lipscomb collaborates with scholars based in United States, United Kingdom and Australia. Jonathan Lipscomb's co-authors include Walid Heneine, Jeffrey A. Johnson, Michael Monsour, J. Gerardo Garcı́a-Lerma, Xierong Wei, LI Jin-fen, Diane Bennett, Ron A. Otten, Mian-er Cong and Silvina Masciotra and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Jonathan Lipscomb

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Lipscomb United States 13 957 790 315 113 73 19 1.1k
Eddie Jackson United States 8 681 0.7× 530 0.7× 416 1.3× 113 1.0× 116 1.6× 9 880
Mian-er Cong United States 11 737 0.8× 605 0.8× 428 1.4× 148 1.3× 81 1.1× 14 1.0k
Ae S. Youngpairoj United States 14 650 0.7× 575 0.7× 261 0.8× 36 0.3× 71 1.0× 22 821
Silvina Masciotra United States 18 1.2k 1.2× 1.1k 1.3× 495 1.6× 65 0.6× 77 1.1× 51 1.4k
Nicola Richardson‐Harman United States 15 512 0.5× 426 0.5× 240 0.8× 251 2.2× 30 0.4× 26 738
Charles Dobard United States 13 657 0.7× 593 0.8× 227 0.7× 242 2.1× 40 0.5× 31 874
Sal Butera United States 11 353 0.4× 320 0.4× 219 0.7× 92 0.8× 66 0.9× 14 543
Jody Schock United States 7 520 0.5× 468 0.6× 186 0.6× 29 0.3× 66 0.9× 7 648
Debra R. Adams United States 14 851 0.9× 669 0.8× 495 1.6× 225 2.0× 134 1.8× 18 1.2k
Reigran Sampoleo United States 6 552 0.6× 226 0.3× 167 0.5× 35 0.3× 51 0.7× 6 721

Countries citing papers authored by Jonathan Lipscomb

Since Specialization
Citations

This map shows the geographic impact of Jonathan Lipscomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lipscomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lipscomb more than expected).

Fields of papers citing papers by Jonathan Lipscomb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lipscomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lipscomb. The network helps show where Jonathan Lipscomb may publish in the future.

Co-authorship network of co-authors of Jonathan Lipscomb

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Lipscomb. A scholar is included among the top collaborators of Jonathan Lipscomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Lipscomb. Jonathan Lipscomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Elliott, Eric I., Jonathan Lipscomb, Bubu A. Banini, et al.. (2024). Acute Hepatitis due to Primary Human Immunodeficiency Virus Infection. Open Forum Infectious Diseases. 11(4). ofae170–ofae170.
2.
Massud, Ivana, Kenji Nishiura, Susan Ruone, et al.. (2024). Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection. Pharmaceutics. 16(3). 384–384.
3.
Makarova, Natalia, M. Melissa Peet, James Mitchell, et al.. (2023). Extended Postexposure Protection Against Vaginal Simian/Human Immunodeficiency Virus Infection With Tenofovir Alafenamide Fumarate/Elvitegravir Inserts in Macaques. The Journal of Infectious Diseases. 229(6). 1791–1795. 2 indexed citations
4.
Dobard, Charles, Natalia Makarova, Kenji Nishiura, et al.. (2020). Long-Acting Cabotegravir Protects Macaques Against Repeated Penile Simian-Human Immunodeficiency Virus Exposures. The Journal of Infectious Diseases. 222(3). 391–395. 12 indexed citations
5.
Massud, Ivana, Mian‐er Cong, Susan Ruone, et al.. (2019). Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques. The Journal of Infectious Diseases. 220(11). 1826–1833. 14 indexed citations
6.
Dobard, Charles, Natalia Makarova, Chuong Dinh, et al.. (2018). Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques. The Journal of Infectious Diseases. 218(8). 1284–1290. 9 indexed citations
7.
Makarova, Natalia, Tara Henning, Chuong Dinh, et al.. (2017). Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis. AIDS. 31(6). 745–752. 12 indexed citations
8.
Dobard, Charles, Sunita Sharma, Urvi M. Parikh, et al.. (2014). Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors. Science Translational Medicine. 6(227). 227ra35–227ra35. 40 indexed citations
9.
Geretti, Anna María, Zoë Fox, Jeffrey A. Johnson, et al.. (2013). Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 8(7). e69266–e69266. 16 indexed citations
10.
11.
Rompay, Koen K. A. Van, Darius Babusis, Yongzhi Geng, et al.. (2012). Compared to Subcutaneous Tenofovir, Oral Tenofovir Disoproxyl Fumarate Administration Preferentially Concentrates the Drug into Gut-Associated Lymphoid Cells in Simian Immunodeficiency Virus-Infected Macaques. Antimicrobial Agents and Chemotherapy. 56(9). 4980–4984. 11 indexed citations
12.
Dobard, Charles, Sunita Sharma, Amy Martin, et al.. (2011). Durable Protection from Vaginal Simian-Human Immunodeficiency Virus Infection in Macaques by Tenofovir Gel and Its Relationship to Drug Levels in Tissue. Journal of Virology. 86(2). 718–725. 93 indexed citations
13.
Farr, Sherry L., Julie A. Nelson, Athena P. Kourtis, et al.. (2010). Addition of 7 Days of Zidovudine Plus Lamivudine to Peripartum Single-Dose Nevirapine Effectively Reduces Nevirapine Resistance Postpartum in HIV-Infected Mothers in Malawi. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(5). 515–523. 20 indexed citations
14.
Garcı́a-Lerma, J. Gerardo, Mian-er Cong, James Mitchell, et al.. (2010). Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection. Science Translational Medicine. 2(14). 14ra4–14ra4. 141 indexed citations
15.
Johnson, Jeffrey A., LI Jin-fen, Xierong Wei, et al.. (2008). Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy. PLoS Medicine. 5(7). e158–e158. 291 indexed citations
16.
Garcı́a-Lerma, J. Gerardo, Ron A. Otten, Shoukat H. Qari, et al.. (2008). Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir. PLoS Medicine. 5(2). e28–e28. 278 indexed citations
17.
18.
Johnson, Jeffrey A., LI Jin-fen, Xierong Wei, et al.. (2007). Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance Mutations. PLoS ONE. 2(7). e638–e638. 56 indexed citations
19.
Slikker, William, et al.. (1985). Time course alterations in tremor and muscarinic receptor binding produced by trimethyltin.. PubMed. 28. 139–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eddie Jackson Breakdown of academic impact, for papers by Mian-er Cong Breakdown of academic impact, for papers by Ae S. Youngpairoj Breakdown of academic impact, for papers by Silvina Masciotra Breakdown of academic impact, for papers by Nicola Richardson‐Harman Breakdown of academic impact, for papers by Charles Dobard Breakdown of academic impact, for papers by Sal Butera Breakdown of academic impact, for papers by Jody Schock Breakdown of academic impact, for papers by Debra R. Adams Breakdown of academic impact, for papers by Reigran Sampoleo
Rankless by CCL
2026